Cargando…
The BRCA1 exon 13 duplication: clinical characteristics of 22 families in Northern Sweden
The clinical management of BRCA1/2 mutation carriers requires accurate cancer risk estimates. Cancer risks vary according to type and location of the mutation and since there is limited information about mutation-specific cancer risks, genotype-phenotype correlation studies are needed. This is a rep...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323134/ https://www.ncbi.nlm.nih.gov/pubmed/30136106 http://dx.doi.org/10.1007/s10689-018-0098-y |